4.6 Article

The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago

Journal

GYNECOLOGIC ONCOLOGY
Volume 135, Issue 2, Pages 285-291

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ygyno.2014.08.029

Keywords

Ovarian cancer; Treatment; Racial disparities; Neighborhood socioeconomic status; Comorbidities

Funding

  1. NIH/NCMHD [P60 MD003424]
  2. American Cancer Society [RSG-13-380-01-CPHPS]
  3. NIH/NCI [2P50CA106743-06]
  4. NATIONAL CANCER INSTITUTE [P50CA106743] Funding Source: NIH RePORTER
  5. National Institute on Minority Health and Health Disparities [P60MD003424] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Background. Less than half of women with ovarian cancer and blacks specifically receive therapy adherent to National Comprehensive Cancer Network (NCCN) guidelines. The purpose is to assess the effect of neighborhood-level socioeconomic status (SES) on black-white treatment differences in a population-based analysis in a highly-segregated community. Methods. Illinois State Cancer Registry data for invasive epithelial ovarian cancer cases diagnosed in Cook County, IL in non-Hispanic white (NHW) or black (NHB) women from 1998 to 2009 was analyzed. As few women receive NCCN-adherent care, variables were constructed to assess extent of treatment, including receipt of: 1) debulking surgery; 2) any surgery; 3) multi-agent chemotherapy; and 4) any chemotherapy. Two measures (concentrated affluence and disadvantage) were used to estimate neighborhood-level SES. Multivariable logistic regression was used to compute odds ratios (OR) and 95% confidence intervals (95% Cl), with generalized linear mixed models to account for hierarchical data. Results. 2766 (81.0%) NHW and 647 (19.0%) NHB women were diagnosed. Adjusting for covariates, NHB were less likely to receive debulking surgery (OR: 039; 95% CI: 030-0.50), any surgery.(OR: 038; 95% CI: 0.29-0.49), multi-agent chemotherapy (OR: 0.56; 95% CI: 0.45-0.71) and any chemotherapy (OR: 0.58; 95% CI: 0.45-0.74). Concentrated affluence but not disadvantage was significant in final models for multi-agent and any chemotherapy, but not debulking or any surgery. Conclusions. Results identify black-white differences consistent across treatments that persist despite adjustment for neighborhood-level SES. Impact. Results advance inequality awareness beyond ideal NCCN-adherent care, indicating inequality exists in delivery of even the most basic oncologic care. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available